首页> 外文期刊>The Journal of Organic Chemistry >Synthesis of Nucleoside Boranophosphoramidate Prodrugs Conjugated with Amino Acids
【24h】

Synthesis of Nucleoside Boranophosphoramidate Prodrugs Conjugated with Amino Acids

机译:氨基酸缀合的核苷硼酸氨基磷酸硼酸盐前药的合成

获取原文
获取原文并翻译 | 示例
           

摘要

Nucleoside boranophosphates and nucleoside amino acid phosphoramidates have been shown to be potent antiviral and anticancer agents with the potential to act as nucleoside prodrugs.A combination of these two types of compounds results in a boranophosphoramidate linkage between the nucleoside and amino acid.This new class of potential prodrugs is expected to possess advantages conferred by both types of parent compounds.Two approaches,specifically the H-phosphonate and oxathiaphospholane approaches,are described here to synthesize nucleoside boranophosphoramidate prodrugs conjugated with amino acids.The H-phosphonate approach involves a key intermediate,silylated nucleoside amino acid phosphoramidite 6,prepared from a series of reactions starting from nucleoside H-phosphonate in the presence of condensing reagent DPCP.Due to the lengthy procedure and the difficulties in removing DPCP from the final products,we switched to the oxathiaphospholane approach in which the DBU-assisted oxathiaphospholane ring-opening process constituted a key step for the generation of nucleoside amino acid boranophosphoramidates 24.We demonstrate that this key step did not cause any measurable C-racemization of boranophos-phorylated amino acids 22.Diastereomers of compounds 24a-f were separated by RP-HPLC.An "adjacent"-type mechanism is proposed to explain the diastereomer ratio in the final products obtained via the oxathiaphospholane approach.A tentative assignment of configuration for the diastereomers was carried out based on the mechanism,molecular modeling,and ~1H NMR.Conclusively,the oxathiaphospholane methodology proved to be more facile and efficient than H-phosphonate chemistry in the preparation of the nucleoside amino acid boranophosphoramidate analogues that are promising as a new type of antiviral prodrugs.
机译:核苷硼酸磷酸酯和核苷氨基酸氨基磷酸酯已被证明是有效的抗病毒剂和抗癌剂,具有潜在的核苷前药作用,这两种类型化合物的组合可在核苷和氨基酸之间形成硼酸氨基硼酸酯键。潜在的前药有望具有两种母体化合物都具有的优势。本文介绍了两种方法,特别是H-膦酸酯和草硫膦膦方法合成与氨基酸结合的核苷硼磷酰胺酸酯前药。H-膦酸酯方法涉及关键的中间体,甲硅烷基化的核苷氨基酸亚磷酰胺6,是由在缩合剂DPCP的存在下,从核苷H-膦酸酯开始的一系列反应制得的。由于过程冗长且难以从最终产物中除去DPCP,我们改用草硫磷化氢方法DBU协助的草ath磷烷的开环过程是生成核苷氨基酸硼磷酰胺酸24的关键步骤。我们证明了这一关键步骤并没有引起可测量的硼磷酰磷酸化氨基酸的22消旋作用。化合物24a-f的非对映异构体由RP-HPLC。提出了一种“相邻”型机理来解释通过氧杂磷杂环烷方法获得的最终产物中的非对映异构体比率。基于该机理,分子模型和〜1H,初步确定了非对映异构体的构型NMR。结论是,在制备有望作为新型抗病毒前药的核苷氨基酸硼基氨基磷酸酯类似物方面,相比于H-膦酸酯化学方法,草硫磷膦方法被证明更加简便有效。

著录项

  • 来源
    《The Journal of Organic Chemistry》 |2005年第6期|p.2171-2183|共13页
  • 作者

    Ping Li; Barbara Ramsay Shaw;

  • 作者单位

    Department of Chemistry,Box 90346,Duke University,Durham,North Carolina 27708-0346;

    Department of Chemistry,Box 90346,Duke University,Durham,North Carolina 27708-0346;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 有机化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号